Dual Screening Test
It involves the calculation of the risk of certain common fetal abnormalities (such as Down’s syndrome) using ultrasound between 11 and 14 weeks of gestation, nuchal translucency and a laboratory screening test using a blood sample from the mother. The dual screening test is not a diagnostic test. Therefore, the presence of these syndromes cannot be established with certainty. It only identifies high-risk pregnant women. Thus, in high-risk pregnancies, definitive diagnostic tests (such as fetal DNA in maternal blood, amniocentesis, chorionic villus biopsy) can be performed.
Pregnancy
Importance of Pre-Pregnancy Check
Pregnancy is a period of about 40 weeks from the date of the last menstrual period, when the fetus develops in the woman’s uterus,
NIPT Test
NIPT, a genetic diagnostic test performed with a small blood sample taken from the mother, gives 99% accuracy in identifying possible genetic diseases (such
